Inhibition of GLI1 by siRNAs or GANT61 showed increased DNA damage, activation of ataxia telangiectasia-mutated protein kinase (ATM)-checkpoint kinase 2 (CHK2) and cell cycle arrest at G1–S and in early S-phase in many tumor cells that aberrantly express GLI1. Here, GLI1 is linked to neoplasm.